#Sustainability #USA #Minneapolis #Climate Goals #Bio-Techne

Bio-Techne: Leading the Charge in Sustainable Practices

Introduction

In the realm of life sciences, Bio-Techne Corporation (NASDAQ: TECH) stands out not just for its innovative tools and reagents, but also for its commitment to environmental responsibility. The company recently announced a significant achievement: validation of its Science Based Targets by the Science Based Targets initiative (SBTi). This validation highlights Bio-Techne's determination to align its operational goals with climate science and global standards.

Achievements in Climate Goals

Emission Reduction Targets

The SBTi has acknowledged Bio-Techne's targets aimed at reducing greenhouse gas emissions. They include:

• - A reduction plan for Scope 1 and 2 emissions by 70% by the year 2031, compared to a 2025 baseline.
• - Ensuring that by fiscal year 2030, 81% of suppliers will adopt science-based targets pertaining to various aspects of their functions including purchased goods and services, and business travel.

This independent validation is essential as it provides stakeholders, including customers and suppliers, with a credible assurance that Bio-Techne's climate ambitions are rooted in scientifically-backed methodologies.

Operational Enhancements

During the 2026 fiscal year, Bio-Techne has shown remarkable progress with:

• - A 49% year-over-year decrease in market-based Scope 1 and 2 emissions.
• - A major leap toward renewable energy, with over 51% of its total electricity consumption now sourced from renewable origins. The company has fully transitioned its Minneapolis headquarters to utilize 100% renewable electricity, further demonstrating its commitment.

Company Leadership Remarks

Kim Kelderman, President and CEO of Bio-Techne, emphasized the importance of these milestones by stating, “Our Science Based Targets validation and progress against those targets demonstrate Bio-Techne's commitment to growing responsibly.” This encapsulates the firm’s dual focus on driving scientific innovation while minimizing ecological footprints.

About Bio-Techne

Bio-Techne Corporation has been at the forefront of life sciences for over fifty years. Based in Minnesota, the company specializes in a diverse range of products including reagents, analytical instruments, and diagnostics. Their extensive portfolio serves various sectors, empowering researchers and clinicians alike to make impactful discoveries.

The organization operates in 34 global locations and boasts a workforce of over 3,000 employees. With an impressive net sales figure of over $1.2 billion for the 2026 fiscal year, Bio-Techne continues to cement its place as an industry leader.

Conclusion

The validation of Bio-Techne's climate goals is more than just a corporate milestone; it represents a commitment to a sustainable future in the life sciences sector. As global challenges related to climate change continue to intensify, Bio-Techne's proactive approach offers a compelling model for other organizations seeking to balance profitability with environmental accountability.

Bio-Techne's story is not just one of business success; it’s a narrative that intertwines innovation with responsibility, demonstrating that even in the pursuit of science, sustainability must be a central tenet of operations.